基于电子医疗数据的信号检测暴露模型框架
An Exposure Model Framework for Signal Detection based on Electronic Healthcare Data
AI总结:
针对电子健康数据信号检测中药物暴露史与不良反应纵向关系建模不足的问题,提出显式建模该关系的暴露模型框架,结合最大似然估计与BIC准则进行模型选择与信号判定,模拟与真实数据验证了其有效性。
摘要:
尽管在药物上市前进行了广泛的安全性评估,某些药物不良反应(ADRs)仍未被检测到。药物警戒的首要目标是识别这些ADRs(即信号)。除了传统的自发报告系统(SRSs)外,电子健康(EHC)数据也被用于信号检测。与SRS不同,EHC数据是纵向的,因此需要对患者的药物暴露史及其随时间对ADR发生的影响进行假设,而许多现有方法隐含地做出了这些假设。我们提出了一个暴露模型框架,显式地建模药物与ADR之间的纵向关系。通过同时考虑多个此类模型,我们可以检测到其他方法可能遗漏的信号。这些模型的参数使用最大似然法进行估计,并采用贝叶斯信息准则(BIC)选择最合适的模型。由于BIC与后验分布相关,它具有双重目的:通过评估零模型的后验概率,既识别最佳拟合模型,又确定信号是否存在。我们通过一项模拟研究评估了该框架的有效性,为此我们开发了一个EHC数据模拟器。此外,我们进行了一项案例研究,将我们的方法应用于四个药物-ADR对,使用包含超过120万被保险人的EHC数据集。该方法和EHC数据模拟器代码作为R包 https://github.com/bips-hb/expard 的一部分公开可用。
英文摘要:
Despite extensive safety assessments of drugs prior to their introduction to the market, certain adverse drug reactions (ADRs) remain undetected. The primary objective of pharmacovigilance is to identify these ADRs (i.e., signals). In addition to traditional spontaneous reporting systems (SRSs), electronic health (EHC) data is being used for signal detection as well. Unlike SRS, EHC data is longitudinal and thus requires assumptions about the patient's drug exposure history and its impact on ADR occurrences over time, which many current methods do implicitly. We propose an exposure model framework that explicitly models the longitudinal relationship between the drug and the ADR. By considering multiple such models simultaneously, we can detect signals that might be missed by other approaches. The parameters of these models are estimated using maximum likelihood, and the Bayesian Information Criterion (BIC) is employed to select the most suitable model. Since BIC is connected to the posterior distribution, it servers the dual purpose of identifying the best-fitting model and determining the presence of a signal by evaluating the posterior probability of the null model. We evaluate the effectiveness of this framework through a simulation study, for which we develop an EHC data simulator. Additionally, we conduct a case study applying our approach to four drug-ADR pairs using an EHC dataset comprising over 1.2 million insured individuals. Both the method and the EHC data simulator code are publicly accessible as part of the R package https://github.com/bips-hb/expard.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。